- This event has passed.
Buprenorphine Waiver Training
August 24, 2019 @ 9:00 am - 1:00 pm
What: Regardless of your specialty, if you see patients experiencing opioid use disorder (OUD), you may want to learn about this life-saving treatment. Medication Assisted Treatment (MAT) of OUD involves use of medication that targets the brain, and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. Research shows that medications and therapy together may be more successful than either treatment method alone.
Physicians require eight hours of training to obtain a waiver from the Drug Enforcement Agency to begin prescribing buprenorphine for OUD. This four-hour training will be the live half of a “half and half” eight-hour training sequence. The link to the online half will be provided to those who complete the live training. Physician assistants and nurse practitioners must take the eight-hour waiver training and an additional 16 hours of training, available for free at PCSSMAT.org.
Who: Providers interested in prescribing buprenorphine (you are qualified if you are an MD, DO, PA or ARNP) and any others who have patient contact (e.g., nurses, medical assistants, pharmacists, psychologists, social workers, community health workers, peers). Having waivered prescribers is important, but MAT is a team sport.
When: Join CPAA on Saturday, August 24, from 9:00am to 1:00pm for a buprenorphine waiver training course.
Where: Providence Centralia Classroom, 914 S Scheuber Rd, Centralia, WA.
Continuing Education: American Academy of Addiction Psychiatry designates this enduring material for a maximum of 4 (four) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This waiver training is sponsored by Cascade Pacific Action Alliance (CPAA) and organized by Lucinda Grande, MD, and Kari Lima, MD. The American Academy of Addiction Psychiatry (AAAP) is the data sponsor for this training.
Contact Sara Rainer with questions or concerns: email@example.com